InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.

JLS Fund is a New York-based venture capital fund specializing in neuromedicine, focusing on psychedelic-inspired therapeutics and neuropsychiatric disorders. They invest in early-stage companies developing innovative treatments and enabling technologies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Founded in 2019, JLS Fund is a venture capital firm based in New York, dedicated to advancing the field of neuromedicine. The fund targets investments in companies that address urgent unmet needs in the treatment of neuropsychiatric disorders through innovative therapies, particularly those inspired by psychedelics and plant-based medicines. JLS Fund is recognized as one of the earliest dedicated venture capital funds in the regulated psychedelic medicine space, combining financial returns with a commitment to category leadership in a rapidly evolving sector. Their portfolio includes notable companies such as Enthea, ProNovo, and Psilera Bioscience, reflecting their focus on breakthrough mental health therapeutics and the infrastructure that supports their delivery.
JLS Fund invests in neuromedicine, with a focus on pre-seed, seed, Series A, and later-stage secondaries transitioning to buyout. The fund's investment thesis includes companies that address urgent unmet needs in the treatment of neuropsychiatric disorders, particularly through innovative psychedelic therapies.
JLS Fund provides strategic support to its portfolio companies, leveraging deep industry knowledge and connections in the psychedelic and neuromedicine sectors. The team’s extensive experience in psychedelic research and philanthropy enhances their ability to guide companies through regulatory challenges and market entry.
JLS Fund focuses on early-stage companies in the neuromedicine sector, particularly those developing psychedelic-derived and inspired therapies. They seek startups that address urgent unmet needs in neuropsychiatric disorders.
Founders can pitch JLS Fund through their website at jls.fund or via email at info@jls.fund. A detailed pitch deck outlining the business model, market opportunity, and team is recommended.
JLS Fund is one of the earliest dedicated VC funds in the regulated psychedelic medicine space, with a strong focus on neuromedicine. Their team has extensive experience in psychedelic research and philanthropy, providing unique insights and connections.
The firm primarily invests in North America, with a specific focus on the United States.
The specific fund size has not been publicly disclosed, but JLS Fund typically invests in early-stage rounds, including pre-seed, seed, and Series A, with check sizes varying based on the stage and needs of the company.
JLS Fund provides strategic support to its portfolio companies, leveraging deep industry knowledge and connections to help navigate regulatory challenges and market entry.
Superscout Pro
Is this page right?Reviewed · How the research works